Morgan Stanley Ignores Einhorn, Remains Positive On Athenahealth, IncMark Melin
Nearly seven days after David Einhorn announced his short attack on Athenahealth, Inc (NASDAQ:ATHN), a Morgan Stanley report doesn't mention the incident in its May 12 research note on the stock.
Athenahealth: Morgan "overweight," notes potential for cost savings in sales, R&D
The report, which has Athenahealth, Inc (NASDAQ:ATHN) as an “overweight” in the portfolio, noted that “Steady state margins reflect the underlying earnings power . . .
This content is exclusively for paying members. Access all of our content on including years of timeless investment news and in depth analysis for only a few dollars a month by signing up here while also supporting quality content and journalism, or learn more about our premium content here
If you are subscribed and having an account error please clear cache and then cookies if that does not work email firstname.lastname@example.org and we will get back to you as quick as humanly possible